Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsDünyaTurkish, translatedFiled 2 days ago

A promising step in cancer treatment! New drug approved from Europe

Original headlineKanser tedavisinde umut veren adım! Avrupa'dan yeni ilaca onay

Open the sourceReported by Dünya, dunya.com, 17 November 2026

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

The European Commission has granted marketing authorization for Daraxonrasib, a new therapy for metastatic pancreatic cancer in adults who have already received at least one prior treatment, following an accelerated review. The approval covers patients whose cancer has spread to other parts of the body, a group with historically limited options. A full assessment report on the drug's clinical benefits is expected to be completed in December, and that verdict will shape how widely the treatment is adopted across EU markets.

Muhabbit's AI wrote this summary in its own words from Dünya's report and translated it from Turkish. It can get details wrong, so check the source.

Named in this story

Daraxonrasib, European Union Commission, pancreatic cancer